Literature DB >> 12209247

Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study.

Daniele Marrelli1, Franco Roviello, Giovanni de Manzoni, Paolo Morgagni, Alberto Di Leo, Luca Saragoni, Alfonso De Stefano, Secondo Folli, Claudio Cordiano, Enrico Pinto.   

Abstract

The aim of this multicenter longitudinal study was to evaluate the pattern of recurrence in patients submitted to potentially curative surgery for intestinal-type and diffuse-type gastric cancer. The study included 412 patients surgically treated at three Italian surgical departments, subdivided into 273 intestinal-type cases (group A) and 139 diffuse-type cases (group B). Recurrence of disease was found in 41% of group A cases and 65% of group B cases (p < 0.0001). The incidence of locoregional, hematogenous, and peritoneal recurrence was 20%, 19%, and 9% in group A, and 27%, 16%, and 34% in group B, respectively; the difference between the two groups was statistically significant for peritoneal recurrence (p < 0.0001). Multivariate analysis identified as prognostic variables lymph node status, depth of invasion, extent of lymphadenectomy, advanced age, and male gender in group A; depth of invasion, extent of lymphadenectomy, tumor size, and lymph node status, in group B. Whereas in group A the incidence of peritoneal recurrence was limited in all subgroups examined, in group B very high rates were observed in cases with infiltration of the serosa, involvement of second-level lymph nodes, or large tumor size. The notable difference in the risk of peritoneal recurrence between the intestinal and diffuse types should be taken into consideration in the therapeutic approach to gastric cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12209247     DOI: 10.1007/s00268-002-6344-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  42 in total

1.  Laparoscopic low anterior resection for hematogenous rectal metastasis from gastric adenocarcinoma: a case report.

Authors:  Sang Woo Lim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  World J Surg Oncol       Date:  2011-11-11       Impact factor: 2.754

2.  Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role?

Authors:  Fabio Carboni; Pasquale Lepiane; Roberto Santoro; Riccardo Lorusso; Pietro Mancini; Massimo Carlini; Eugenio Santoro
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.

Authors:  Ahmet Bilici; Fatih Selcukbiricik
Journal:  Tumour Biol       Date:  2015-03-12

Review 4.  Clinical impact of molecular classifications in gastric cancer.

Authors:  Daniele Marrelli; Karol Polom; Alessandro Neri; Franco Roviello
Journal:  Updates Surg       Date:  2018-05-23

5.  Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience.

Authors:  Alberto Di Leo; Daniele Marrelli; Franco Roviello; Marco Bernini; AnnaMaria Minicozzi; Simone Giacopuzzi; Corrado Pedrazzani; Luca Gian Baiocchi; Giovanni de Manzoni
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

6.  Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.

Authors:  Mitsuro Kanda; Hisaharu Oya; Shuji Nomoto; Hideki Takami; Dai Shimizu; Ryoji Hashimoto; Satoshi Sueoka; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

7.  Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer.

Authors:  Yunben Yang; Yongfu Shao; Mengying Zhu; Qier Li; Fang Yang; Xuwen Lu; Chunjing Xu; Bingxiu Xiao; Yanke Sun; Junming Guo
Journal:  Tumour Biol       Date:  2015-08-18

8.  Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.

Authors:  Tommaso Cioppa; Marco Vaira; Camilla Bing; Silvia D'Amico; Alessandro Bruscino; Michele De Simone
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer.

Authors:  Mohammad Mobayed; Lance K Heilbrun; Anthony F Shields; Tara Washington; Raghu Venkatramanamoorthy; Philip A Philip; Bassel F El-Rayes
Journal:  Case Rep Oncol       Date:  2009-11-21

10.  Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Masanori Goto; Moriya Iwaizumi; Hiroyuki Konno; Hideki Kataoka; Masami Yamada; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.